Drug Type Small molecule drug |
Synonyms VLX 2000, VLX2000 |
Target |
Mechanism ALOX12 inhibitors(12-lipoxygenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | US | ![]() | 01 Jan 2025 |